Jay M. Moyes, Chief Financial Officer at MYRIAD GENETICS INC (MYGN), sold 28,196 shares at $47.09 ($1.3M) on 2007-09-13, disclosed to the SEC on 2007-09-14.
Open-market sale of $1.3M MYGN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.08 | 3,344 | $157K | 11.8% |
| 2 | $47.09 | 6,756 | $318K | 23.9% |
| 3 | $47.10 | 3,244 | $153K | 11.5% |
| 4 | $47.11 | 2,530 | $119K | 9.0% |
| 5 | $47.12 | 2,703 | $127K | 9.6% |
| 6 | $47.13 | 1,100 |
| $52K |
| 3.9% |
| 7 | $47.46 | 1,500 | $71K | 5.3% |
| 8 | $47.47 | 800 | $38K | 2.9% |
| 9 | $47.48 | 1,733 | $82K | 6.2% |
| 10 | $47.48 | 467 | $22K | 1.7% |
| 11 | $47.49 | 3,423 | $163K | 12.2% |
| 12 | $47.50 | 200 | $10K | 0.7% |
| 13 | $47.51 | 100 | $5K | 0.4% |
| 14 | $47.54 | 200 | $10K | 0.7% |
| 15 | $47.55 | 96 | $5K | 0.3% |
| Total | $47.21 avg | 28,196 | $1.3M | 100% |
| Filing → |
| SINT | BUY | 2025-08-27 | $11K | — | Filing → |
| PBYI | SELL | 2025-06-17 | $75K | — | Filing → |
| PBYI | SELL | 2024-06-17 | $73K | — | Filing → |